The Discounted Cash Flow (DCF) valuation of Medite Cancer Diagnostics Inc (MDIT) is (3.15) USD. With the latest stock price at 0.00 USD, the upside of Medite Cancer Diagnostics Inc based on DCF is -3146606.0%.
Based on the latest price of 0.00 USD and our DCF valuation, Medite Cancer Diagnostics Inc (MDIT) is a sell. selling MDIT stocks now will result in a potential gain of 3146606.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.4% - 6.1% | 5.2% |
| Long-term Growth Rate | 3.0% - 4.2% | 3.6% |
| Fair Price | (20.15) - (1.77) | (3.15) |
| Upside | -20146510.0% - -1771755.3% | -3146606.0% |